CellTolerance Expands Operations to Austria

We are excited to announce that CellTolerance is expanding operations into Austria, marking a significant milestone in our European growth strategy.

This expansion will enable Austrian gastroenterologists and their patients to access our innovative confocal laser endomicroscopy technology for real-time detection of atypical food allergies.

The Austrian market represents a key opportunity to serve patients suffering from irritable bowel syndrome and functional dyspepsia who have not found relief through traditional approaches.

"We're committed to making CellTolerance technology accessible to patients across Europe," said [Executive Name]. "Austria's strong healthcare infrastructure and focus on patient-centered care make it an ideal location for our expansion."

Training programs for Austrian clinicians will begin in Q2 2025.